[go: up one dir, main page]

MX2009004625A - Derivados de 3-amino-pirazol-4-carboxamida utiles como inhibidores de proteina cinasas. - Google Patents

Derivados de 3-amino-pirazol-4-carboxamida utiles como inhibidores de proteina cinasas.

Info

Publication number
MX2009004625A
MX2009004625A MX2009004625A MX2009004625A MX2009004625A MX 2009004625 A MX2009004625 A MX 2009004625A MX 2009004625 A MX2009004625 A MX 2009004625A MX 2009004625 A MX2009004625 A MX 2009004625A MX 2009004625 A MX2009004625 A MX 2009004625A
Authority
MX
Mexico
Prior art keywords
pyrazole
inhibitors
amino
protein kinases
derivatives useful
Prior art date
Application number
MX2009004625A
Other languages
English (en)
Inventor
Patricia Imbach
Philipp Holzer
Pascal Furet
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009004625A publication Critical patent/MX2009004625A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención se refiere a compuestos heterocíclicos novedosos de la fórmula (I), en donde todas las variables son como se define en la especificación, en forma libre o en forma de sal, a su preparación, a su uso como medicamentos y a medicamentos que los comprenden. (ver fórmula (I)).
MX2009004625A 2006-10-30 2007-10-29 Derivados de 3-amino-pirazol-4-carboxamida utiles como inhibidores de proteina cinasas. MX2009004625A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06123163 2006-10-30
PCT/EP2007/061636 WO2008052974A1 (en) 2006-10-30 2007-10-29 3-amino-pyrazole-4-carboxamide derivatives useful as inhibitors of protein kinases

Publications (1)

Publication Number Publication Date
MX2009004625A true MX2009004625A (es) 2009-05-15

Family

ID=37890336

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009004625A MX2009004625A (es) 2006-10-30 2007-10-29 Derivados de 3-amino-pirazol-4-carboxamida utiles como inhibidores de proteina cinasas.

Country Status (10)

Country Link
US (1) US20100093821A1 (es)
EP (1) EP2079702A1 (es)
JP (1) JP2010508325A (es)
KR (1) KR20090074791A (es)
CN (1) CN101522636A (es)
AU (1) AU2007316190A1 (es)
BR (1) BRPI0717873A2 (es)
CA (1) CA2667927A1 (es)
MX (1) MX2009004625A (es)
WO (1) WO2008052974A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009276873A1 (en) 2008-07-31 2010-02-04 Merck Sharp & Dohme Corp. Inhibitors of janus kinases
KR100961410B1 (ko) 2008-10-14 2010-06-09 (주)네오팜 단백질 키나제 억제제로서 헤테로사이클릭 화합물
KR101646180B1 (ko) 2014-09-22 2016-08-05 한양대학교 에리카산학협력단 N-(5-아릴아미도-2-메틸페닐)-5-메틸이소옥사졸-4-카복스아미드 유도체, 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 fms 키나아제 저해제
CN104876879B (zh) * 2015-04-14 2018-05-18 中国科学院合肥物质科学研究院 一种bcr-abl激酶抑制剂

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0409949A (pt) * 2003-05-01 2006-04-25 Bristol Myers Squibb Co compostos de pirazol amida aril-substituìda úteis como inibidores de cinase
WO2005009973A1 (en) * 2003-06-26 2005-02-03 Novartis Ag 5-membered heterocycle-based p38 kinase inhibitors

Also Published As

Publication number Publication date
KR20090074791A (ko) 2009-07-07
EP2079702A1 (en) 2009-07-22
BRPI0717873A2 (pt) 2013-10-29
AU2007316190A1 (en) 2008-05-08
JP2010508325A (ja) 2010-03-18
WO2008052974A1 (en) 2008-05-08
US20100093821A1 (en) 2010-04-15
CN101522636A (zh) 2009-09-02
CA2667927A1 (en) 2008-05-08

Similar Documents

Publication Publication Date Title
MX2009012066A (es) Imidazopirinas sustituidas como inhibidoras de cinasa de lipido p13k.
MX2009011964A (es) Derivados heterociclicos pirrolo-nitrogenosos, su preparacion y uso farmaceutico.
WO2009132774A8 (en) New substituted indolin-2-one derivatives and their use as p38 mitogen-activated kinase inhibitors
MX2009004623A (es) Imidazopiridazinas como inhibidores de la lipido cinasa pi3k.
GEP20135785B (en) Pyrrolopyrimidine compounds as cdk inhibitors
MX2009000884A (es) Derivados de piridizinona.
MX2010008719A (es) Pirrolo [2,-d] piridinas y usos de las mismas como inhibidores de cinasa de tirosina.
WO2006106326A8 (en) Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
MX2009006706A (es) Compuestos heterociclicos biciclicos como inhibidores del receptor del factor de crecimiento de fibroblastos.
EA201071339A1 (ru) Фосфорсодержащие производные в качестве ингибиторов киназы
SG140591A1 (en) Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
MY148851A (en) Dihydropyridine derivatives as useful as protein kinase inhibitors
EA201200174A1 (ru) Производные оксазина и их применение в качестве ингибиторов bace для лечения неврологических нарушений
NO20083427L (no) Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
EA200901133A1 (ru) Производные дианилинопиримидина как ингибиторы киназы wee1, фармацевтическая композиция и применение
MX2010006799A (es) Benzofuropirimidinonas como inhibidores de la proteina cinasa.
WO2009024611A3 (en) 4-benzylaminoquinolines, pharmaceutical compositions containing them and their use
MY149512A (en) Pyrazolylaminopyridine derivatives useful as kinase inhibitors
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
MX340714B (es) Inhibidores de hsp90.
MA32727B1 (fr) Pyrazolylaminopyridines au titre d'inhibiteurs de fak
PL1899329T3 (pl) Pirymidyno-podstawione pochodne benzimidazolu jako inhibitory kinaz białkowych
WO2008049855A3 (en) 7-azaindole derivatives as c-met kinase inhibitors
JO2682B1 (en) Derivatives of alkynil-8.1-naphthayridone, preparations thereof and therapeutic use thereof
WO2008061108A3 (en) Phthalazine derivatives

Legal Events

Date Code Title Description
FA Abandonment or withdrawal